D. Sémeril, D. Matt et al.
FULL PAPER
2-N-(2,6-Dimethoxybenzyl)-5-N-[4(24),6(10),12(16),18(22)-tetra-
hanced by rigidly fixing the TPR unit (after chemical modi-
fication of the ligand) above the cavity entrance, thereby
increasing its time-averaged steric bulk.
methylenedioxy-2,8,14,20-tetrapentylresorcin[4]arene-5-yl]imid-
1
azolinium Bromide (3): Yield 0.249 g (90%). H NMR (400 MHz,
3
CDCl3): δ = 9.85 (s, 1 H, NCHN), 7.34 [t, J = 8.5 Hz, 1 H, ArH,
(CH3O)2C6H3], 7.33 (s, 1 H, ArH, resorcinarene), 7.29 (br. s, 1 H,
NCHCHN), 7.21 (br. s, 1 H, NCHCHN), 7.12 (s, 3 H, ArH, resor-
cinarene), 6.64 (s, 2 H, ArH, resorcinarene), 6.60 [d, J = 8.5 Hz,
Conclusions
3
We have shown that the mono-TPR-substituted imid-
azolium salts used in this study efficiently catalyse the cop-
per-catalysed arylation of cinnamyl bromide with phenyl-
magnesium bromide. The intrinsic ability of the bulky TPR
group to induce γ-selectivity was found to be moderate, but
formation of the branched product could be significantly
increased by attaching appropriate substituents to the sec-
ond nitrogen atom, with the highest b/l ratio being obtained
for the imidazolium salts combining TPR and mesityl sub-
stituents. A rational way to improve the γ-selectivity with
TPR substituted NHCs could involve restricting the rota-
tional freedom of the carbene ring about the N–C(resorcin-
arenyl) moiety so as to force the metal centre to remain
located permanently above the cavity entrance, and conse-
quently render the steric effects of the TPR group predomi-
nant over those of the N2-substituent. This could then also
promote possible cavity effects associated with the receptor
properties of the resorcinarene unit. Modification of the
electronic properties of such ligands could also be envis-
aged.
2 H, ArH, (CH3O)2C6H3], 6.53 (s, 1 H, ArH, resorcinarene), 5.77
2
(s, 2 H, NCH2Ar), 5.72 and 4.65 (AB spin system, J = 7.2 Hz, 4
H, OCH2O), 5.60 and 4.77 (AB spin system, 2J = 7.5 Hz, 4 H,
3
3
OCH2O), 4.75 (t, J = 7.8 Hz, 2 H, CHCH2), 4.70 (t, J = 8.1 Hz,
2 H, CHCH2), 3.89 (s, 6 H, OCH3), 2.30–2.16 (m, 8 H, CHCH2),
3
1.49–1.29 (m, 24 H, CH2CH2CH2CH3), 0.91 (t, J = 6.9 Hz, 12 H,
CH2CH3) ppm. 13C NMR (100 MHz, CDCl3): δ = 158.92–104.23
(ArC), 137.56 (s, NCN), 122.90 (s, NCHCHN), 117.79 (s,
NCHCHN), 101.17 (s, OCH2O), 99.57 (s, OCH2O), 56.30 (s,
OCH3), 43.12 (s, NCH2Ar), 36.80 (s, CHCH2), 36.49 (s, CHCH2),
32.17 (s, CH2CH2CH3), 32.05 (s, CH2CH2CH3), 30.12 (s, CHCH2),
29.90 (s, CHCH2), 27.70 (s, CHCH2CH2), 27.65 (s, CHCH2CH2),
22.82 (s, CH2CH3), 22.79 (s, CH2CH3), 14.24 (s, CH2CH3), 14.22 (s,
CH2CH3) ppm. MS (ESI-TOF): m/z = 1033.54 [M – Br]+ (expected
isotopic profile). C64H77BrN2O10 (1114.21): calcd. C 68.99, H 6.97,
N 2.51; found C 69.12, H 7.17, N 2.39.
2-N-[4(24),6(10),12(16),18(22)-Tetramethylenedioxy-2,8,14,20-tetra-
pentylresorcin[4]arene-5-methyl]-5-N-phenyl-imidazolinium Bromide
1
(7): Yield 0.249 g (95%). H NMR (400 MHz, CDCl3): δ = 10.86
(s, 1 H, NCHN), 7.69 (d, 3J = 7.2 Hz, 2 H, ArH, Ph), 7.60–7.51
(m, 3 H, ArH, Ph), 7.47 (br. s, 1 H, NCHCHN), 7.36 (br. s, 1 H,
NCHCHN), 7.21 (s, 1 H, ArH, resorcinarene), 7.09 (s, 1 H, ArH,
resorcinarene), 7.08 (s, 2 H, ArH, resorcinarene), 6.55 (s, 2 H, ArH,
resorcinarene), 6.48 (s, 1 H, ArH, resorcinarene), 6.17 and 4.55 (AB
Experimental Section
2
spin system, J = 7.4 Hz, 4 H, OCH2O), 5.80 (s, 2 H, NCH2), 5.64
2
3
and 4.45 (AB spin system, J = 7.2 Hz, 4 H, OCH2O), 4.72 (t, J
General Experimental Methods: All manipulations were performed
in Schlenk-type flasks under dry nitrogen. Solvents were dried by
conventional methods and distilled immediately prior to use.
CDCl3 was passed down a 5 cm thick alumina column and stored
under nitrogen over molecular sieves (4 Å). Routine 1H and
13C{1H} NMR spectra were recorded with Bruker FT instruments
3
= 8.2 Hz, 2 H, CHCH2), 4.70 (t, J = 8.2 Hz, 2 H, CHCH2), 2.33–
2.08 (m, 8 H, CHCH2), 1.43–1.29 (m, 24 H, CH2CH2CH2CH3),
0.90 (t, 3J = 7.2 Hz, 6 H, CH2CH3), 0.90 (t, 3J = 7.2 Hz, 6 H,
CH2CH3) ppm. 13C NMR (100 MHz, CDCl3): δ = 155.37–116.81
(ArC), 134.56 (s, NCN), 122.05 (s, NCHCHN), 119.88 (s,
NCHCHN), 100.53 (s, OCH2O), 99.68 (s, OCH2O), 44.23 (s,
NCH2 ), 36.76 (s, CHCH2 ), 36.45 (s, CHCH2 ), 32.14 (s,
CH2CH2CH3), 32.11 (s, CH2CH2CH3), 30.02 (s, CHCH2), 29.92
(s, CHCH2), 27.67 (s, CHCH2CH2), 22.80 (s, CH2CH3), 22.78 (s,
CH2CH3), 14.21 (s, CH2CH3) ppm. MS (ESI-TOF): m/z = 973.53
[M – Br]+ (expected isotopic profiles). C62H73BrN2O8 (1054.16):
calcd. C 70.64, H 6.98, N 2.55; found C 70.49, H 7.02, N 2.64.
1
(AVANCE 400). H NMR spectra were referenced to residual pro-
tiated solvents (δ = 7.26 ppm for CDCl3) and 13C NMR chemical
shifts are reported relative to deuteriated solvents (δ = 77.16 ppm
for CDCl3). Chemical shifts and coupling constants are reported
in ppm and in Hz, respectively. Elemental analyses were performed
by the Service de Microanalyse, Institut de Chimie, Université de
Strasbourg. 2-N-Benzyl-5-N-[4(24),6(10),12(16),18(22)-tetrameth-
ylenedioxy-2,8,14,20-tetrapentylresorcin[4]arene-5-yl]imidazolin-
ium bromide (1),[13] 2-N-[4(24),6(10),12(16),18(22)-tetramethyl-
enedioxy-2,8,14,20-tetrapentylresorcin[4]arene-5-methyl]-5-N-
[4(24),6(10),12(16),18(22)-tetramethylenedioxy-2,8,14,20-tetrapent-
ylresorcin[4]arene-5-yl]imidazolinium bromide (2),[12] 5-N-imid-
azolyl-4(24),6(10),12(16),18(22)-tetramethylenedioxy-2,8,14,20-
tetrapentylresorcin[4]arene (5),[13] 2-N-[4(24),6(10),12(16),18(22)-
tetramethylenedioxy-2,8,14,20-tetrapentylresorcin[4]arene-5-
methyl]-5-N-[25,26,27,28-tetrabenzyloxycalix[4]arene-5-yl]imid-
azolinium bromide (8),[12] and 2,6-dimethoxybenzyl bromide[30]
were prepared according to reported procedures.
2-N-[2,4,6-Trimethylphenyl]-5-N-[4(24),6(10),12(16),18(22)-tetra-
methylenedioxy-2,8,14,20-tetrapentylresorcin[4]arene-5-yl]imid-
azolinium Triflate (4): A mixture of N-resorcinarenyl-imidazole 5
(0.500 g, 0.57 mmol), dimesitylidonium salt (0.437 g, 0.85 mmol)
and [Cu(OTf)2] (0.010 g, 0.03 mmol, 5 mol-%) in DMF (3 mL) was
stirred at 100 °C for 16 h. The solvent was then removed under
reduced pressure and the solid residue was purified by flash
chromatography (acetone/MeOEt, 10:90 v/v), yield 0.309 g (48%).
1H NMR (500 MHz, CDCl3): δ = 9.1 (s, 1 H, NCHN), 7.55 (br. s,
1 H, NCHCHN), 7.41 (s, 1 H, ArH, resorcinarene), 7.36 (s br, 1
H, NCHCHN), 7.15 (s, 2 H, ArH, resorcinarene), 7.13 (s, 1 H,
ArH, resorcinarene), 7.03 (s, 2 H, ArH, mesityl), 6.53 (s, 2 H, ArH,
resorcinarene), 6.46 (s, 1 H, ArH, resorcinarene), 5.66 and 4.47 (AB
spin system, 2J = 7.5 Hz, 4 H, OCH2O), 5.53 and 4.68 (AB spin
system, 2J = 7.5 Hz, 4 H, OCH2O), 4.73 (t, 3J = 8.0 Hz, 2 H,
General Procedure for the Preparation of the Imidazolium Salts 3
and 7: N-Arylimidazole (0.25 mmol) and alkyl bromide
(0.25 mmol) were dissolved in CHCl3 (10 mL). The reaction mix-
ture was then heated to reflux for 2 d. After cooling to room tem-
perature, the solvent was removed under vacuum. The solid was
washed with pentane and recrystallised from CH2Cl2/isopropyl
ether to afford the corresponding imidazolium salt.
3
CHCH2), 4.73 (t, J = 8.0 Hz, 2 H, CHCH2), 2.34 (s, 3 H, p-CH3-
mesityl), 2.32–2.07 (m, 8 H, CHCH2), 2.07 (s, 6 H, o-CH3-mesityl),
3
1.46–1.32 (m, 24 H, CH2CH2CH2CH3), 0.92 (t, J = 7.5 Hz, 6 H,
7314
www.eurjoc.org
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2015, 7310–7316